HMGB1 and serum lipopolysaccharide activity: Earlier studies demonstrated that metformin reduced mortality in a mouse model of lethal endotoxemia by inhibiting HMGB1 release; inhibition of NF-κB-induced TNF-α activation and AMPK activation were the mechanisms contributing to the protective effects [59,60].